Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Immunologic Determinants of Inhibitor Development in Previously Untreated Patients With Hemophilia

NCT01652027 is registered in ClinicalTrials.gov with The University of Texas Health Science Center, Houston as lead sponsor.

NCT NCT01652027
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01652027 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Immunologic Determinants of Inhibitor Development in Previously Untreated Patients With Hemophilia
Lead sponsor
The University of Texas Health Science Center, Houston
Phase
Observational
Overall status
Completed
Start date
July 31, 2011
Completion date
March 31, 2020
Enrollment
25 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

hemophilia a